Literature DB >> 9143242

HPRT mutant T-cell lines from multiple sclerosis patients recognize myelin proteolipid protein peptides.

J L Trotter1, C A Damico, A H Cross, C M Pelfrey, R W Karr, X T Fu, H F McFarland.   

Abstract

Mutation of the hypoxanthine-guanine phosphoribosyl transferase (HPRT) gene in a T-cell is believed to be an indication that the T-cell has been activated and has proliferated in vivo. HPRT mutant T-cell lines were generated from peripheral blood mononuclear cells from patients with MS and control subjects. More lines were isolated from the MS patients than from the control subjects. Using stringent criteria for recognition, none of the lines from MS-affected or control subjects recognized intact myelin basic protein (MBP) or myelin proteolipid protein (PLP) molecules. Using stringent criteria, two of the 10 MS patients harbored mutant lines each recognizing distinct PLP peptides (PLP peptide 40-60 recognized by 3 lines from one patient and PLP peptide 178-191 recognized by 2 lines from the other patient). A single line recognizing PLP peptide 89-106 was derived from 1 of 7 normal controls. HPRT mutant lines recognizing multiple epitopes of PLP which spanned much of the molecule could be isolated from MS patients, and to a lesser extent, normal subjects.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9143242     DOI: 10.1016/s0165-5728(97)00007-6

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  10 in total

1.  Skewed autoantibody reactivity to the extracellular domain of myelin oligodendrocyte glycoprotein in multiple sclerosis.

Authors:  Maria V Tejada-Simon; Jian Hong; Victor M Rivera; Jingwu Z Zhang
Journal:  Immunology       Date:  2002-12       Impact factor: 7.397

2.  Decreased dependence of myelin basic protein-reactive T cells on CD28-mediated costimulation in multiple sclerosis patients. A marker of activated/memory T cells.

Authors:  A E Lovett-Racke; J L Trotter; J Lauber; P J Perrin; C H June; M K Racke
Journal:  J Clin Invest       Date:  1998-02-15       Impact factor: 14.808

3.  Multiparameter Flow Cytometric Assays to Quantify Effector and Regulatory T-Cell Function in Multiple Sclerosis.

Authors:  Sushmita Sinha; Michael P Crawford; Sterling B Ortega; Nitin J Karandikar
Journal:  J Mult Scler (Foster City)       Date:  2015-01

4.  Hla-DR2-restricted responses to proteolipid protein 95-116 peptide cause autoimmune encephalitis in transgenic mice.

Authors:  K Kawamura; T Yamamura; K Yokoyama; D H Chui; Y Fukui; T Sasazuki; H Inoko; C S David; T Tabira
Journal:  J Clin Invest       Date:  2000-04       Impact factor: 14.808

Review 5.  TCR peptide therapy in human autoimmune diseases.

Authors:  A A Vandenbark; E Morgan; R Bartholomew; D Bourdette; R Whitham; D Carlo; D Gold; G Hashim; H Offner
Journal:  Neurochem Res       Date:  2001-06       Impact factor: 3.996

Review 6.  Insights into the immunopathogenesis of multiple sclerosis.

Authors:  Niels Hellings; Jef Raus; Piet Stinissen
Journal:  Immunol Res       Date:  2002       Impact factor: 2.829

Review 7.  Molecular characterization of hypoxanthine guanine phosphoribosyltransferase mutant T cells in human blood: The concept of surrogate selection for immunologically relevant cells.

Authors:  Noah A Kaitz; Cindy L Zuleger; Peng Yu; Michael A Newton; Richard J Albertini; Mark R Albertini
Journal:  Mutat Res Rev Mutat Res       Date:  2022-03-11       Impact factor: 7.015

8.  B cells limit epitope spreading and reduce severity of EAE induced with PLP peptide in BALB/c mice.

Authors:  Jeri-Anne Lyons; Michael J Ramsbottom; Robert J Mikesell; Anne H Cross
Journal:  J Autoimmun       Date:  2008-06-09       Impact factor: 7.094

Review 9.  Autologous T-cell vaccination for multiple sclerosis: a perspective on progress.

Authors:  Arthur A Vandenbark; Rivka Abulafia-Lapid
Journal:  BioDrugs       Date:  2008       Impact factor: 5.807

10.  Field Synopsis and Re-analysis of Systematic Meta-analyses of Genetic Association Studies in Multiple Sclerosis: a Bayesian Approach.

Authors:  Jae Hyon Park; Joo Hi Kim; Kye Eun Jo; Se Whan Na; Michael Eisenhut; Andreas Kronbichler; Keum Hwa Lee; Jae Il Shin
Journal:  Mol Neurobiol       Date:  2017-10-12       Impact factor: 5.590

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.